Welcome to our investor pages

Medical technology company Optomed is leading producer of handheld fundus cameras globally.

Current highlights

Interim Report, January – March 2026 Interim Report, January – March 2026 presentation Annual Report 2025 Optomed as an investment

Key figures

Net sales 17.1 EUR, million
Gross margin 63,6 %
EBITDA -3,5 EUR, million
Equity ratio 75,1 %

Share Price
Nasdaq Helsinki Stock Exchange

Interim Report,
January – March 2026

Latest releases

Investor events

Aug 14 - Aug 14, 2026

Half-Year Financial Report for 1 January – 30 June 2026

Nov 6 - Nov 6, 2026

Interim Report for 1 January – 30 September 2026

May 6 - May 6, 2026

Interim Report for 1 January – 31 March 2026

Feb 10 - Feb 10, 2026

Financial Statement Bulletin for 1 January – 31 December 2025

Nov 7 - Nov 7, 2024

Interim Report for 1 January – 30 September 2024

Aug 8 - Aug 8, 2024

Half-Year Financial Report for 1 January – 30 June 2024

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

Business

Complete solutions for screening – in any location.

Strategy

The company has a long-term growth strategy comprising three key paths.

Key Figures

Read the latest key figures.